Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.056,43
0,27%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Adma Biologics Inc (ADMA) Adma Biologics Inc (ADMA) Notizie

ADMA

Adma Biologics (ADMA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ADMA
DataOraFonteTitoloSimboloCompagnia
02/05/202413:00GlobeNewswire Inc.ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:ADMAAdma Biologics Inc
11/03/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
11/03/202417:19Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ADMAAdma Biologics Inc
11/03/202412:00GlobeNewswire Inc.ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®NASDAQ:ADMAAdma Biologics Inc
09/03/202403:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
05/03/202413:00GlobeNewswire Inc.ADMA Biologics to Participate in the Raymond James Institutional Investor ConferenceNASDAQ:ADMAAdma Biologics Inc
28/02/202422:10GlobeNewswire Inc.ADMA Biologics Announces CFO TransitionNASDAQ:ADMAAdma Biologics Inc
28/02/202422:05GlobeNewswire Inc.ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
21/02/202422:05GlobeNewswire Inc.ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:ADMAAdma Biologics Inc
21/02/202413:00GlobeNewswire Inc.ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlyticsNASDAQ:ADMAAdma Biologics Inc
14/02/202417:50Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADMAAdma Biologics Inc
08/01/202413:00GlobeNewswire Inc.ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
18/12/202322:05GlobeNewswire Inc.ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares ManagementNASDAQ:ADMAAdma Biologics Inc
12/12/202313:00GlobeNewswire Inc.ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and OlderNASDAQ:ADMAAdma Biologics Inc
16/11/202313:00GlobeNewswire Inc.ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MDNASDAQ:ADMAAdma Biologics Inc
08/11/202323:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADMAAdma Biologics Inc
08/11/202322:05GlobeNewswire Inc.ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
01/11/202312:00GlobeNewswire Inc.ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023NASDAQ:ADMAAdma Biologics Inc
02/10/202322:46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
22/08/202323:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ADMAAdma Biologics Inc
18/08/202318:58Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:ADMAAdma Biologics Inc
09/08/202322:05GlobeNewswire Inc.ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
02/08/202313:00GlobeNewswire Inc.ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023NASDAQ:ADMAAdma Biologics Inc
06/06/202322:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMAAdma Biologics Inc
22/05/202313:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADMAAdma Biologics Inc
10/05/202323:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMAAdma Biologics Inc
10/05/202322:05GlobeNewswire Inc.ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
03/05/202313:00GlobeNewswire Inc.ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023NASDAQ:ADMAAdma Biologics Inc
02/05/202313:00GlobeNewswire Inc.ADMA Biologics Announces Amendment to Credit AgreementNASDAQ:ADMAAdma Biologics Inc
13/04/202322:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ADMAAdma Biologics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ADMA

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
TRN
Terna Trasmissione Elett...
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network